GRAIL Says FDA Advisory Committee To Review GRAIL Galleri PMA Application On September 23
GRAL•FDA advisory committee meeting scheduled
- GRAIL announces FDA advisory committee meeting to review premarket approval application for the Galleri® multi-cancer early detection test.
- GRAIL said the FDA advisory committee will review the GRAIL Galleri PMA application on Sept. 23, 2026.
